HonorHealth appoints Dr Nicholas Schork to lead AI-driven disease interception research, reflecting an industry shift towards prevention.

AstraZeneca and Viseven win the 2025 HBA ACE Awards for innovative workforce and community programmes shaping the future of healthcare.

AbbVie to invest $195m in manufacturing expansion as pharma rushes to boost domestic capacity ahead of expected drug import tariffs.

Bayer announces deal with Kumquat for a pancreatic cancer KRAS inhibitor, plus, promising mRNA vaccine research emerges from Phase 1 trial.

Ireland could become a global leader in FemTech innovation, but only if it acts now, claims a new report by Health Innovation Hub Ireland.

A patient case study has uncovered a potential link between beta-HPV and the common skin cancer, cutaneous squamous cell carcinoma (cSCC).

NHS launches the first gonorrhoea vaccine programme in England to reduce infections and tackle the rise of antibiotic resistance.

Two major health agencies are facing leadership reshuffles, with the resignations of the FDA’s Vinay Prasad and NICE’s Dr Sam Roberts.